Y-mabs Therapeutics Stock Fair Value – Y-mAbs Therapeutics Joins Nasdaq Biotechnology Index
🌥️Trending News Y-MABS ($NASDAQ:YMAB): Y-mAbs Therapeutics recently announced that it will be joining the Nasdaq Biotechnology Index, a select group [...]
Y-MABS THERAPEUTICS Records 63.1% Year-Over-Year Revenue Increase in Q3 of 2023
☀️Earnings Overview Y-MABS THERAPEUTICS ($NASDAQ:YMAB) reported a total revenue of USD 20.4 million for the third quarter of fiscal year [...]
Y-MABS THERAPEUTICS Reports Positive Earnings Results for Q2 FY 2023
☀️Earnings Overview Y-MABS THERAPEUTICS ($NASDAQ:YMAB) announced their earnings results for the second quarter of fiscal year 2023, which concluded on [...]
Y-mAbs Therapeutics to Release Quarterly Earnings Results on Monday, May 8th
Trending News 🌥️ Y-MABS ($NASDAQ:YMAB): Y-mAbs Therapeutics, a clinical-stage biopharmaceutical company, is set to release its quarterly earnings results at [...]
Y-mAbs Therapeutics Surpasses Expectations with Increased Revenue and Earnings
Trending News ☀️ Y-MABS ($NASDAQ:YMAB): Y-mAbs Therapeutics, a biopharmaceutical company focused on making novel therapies for cancer, has surpassed expectations [...]
How Shareholders Can Take Advantage of Y-mAbs Therapeutics Stock Price Drop
Trending News 🌥️ Y-MABS ($NASDAQ:YMAB): Shareholders of Y-mAbs Therapeutics Inc. may be looking for ways to take advantage of the [...]
Y-mAbs Therapeutics Reports Impressive Financial Results, Beats Expectations
Trending News ☀️ Y-MABS ($NASDAQ:YMAB): Y-mAbs Therapeutics reported a major financial success this quarter, with GAAP earnings per share of [...]
Investors in Y-mAbs Therapeutics, With Losses Encouraged to Act Before Monday’s Deadline.
Trending News 🌧️ Y-MABS ($NASDAQ:YMAB): Investors in Y-mAbs Therapeutics, Inc. have been encouraged to act quickly before Monday's deadline by [...]
Y-mAbs Shareholders Urged to Take Action Before March Deadline by Jakubowitz Law.
Trending News 🌥️ Y-MABS ($NASDAQ:YMAB): Jakubowitz Law is reminding Y-mAbs shareholders of the upcoming lead plaintiff deadline of March. This [...]
Investors of Y-mAbs Therapeutics, Encouraged to Take Action After Sustaining Losses
Trending News 🌧️ Y-MABS ($NASDAQ:YMAB): Investors of Y-mAbs Therapeutics, Inc., a biopharmaceutical company, have recently been encouraged to take action [...]
